Back to Search Start Over

4CPS-190 Analysis of ibrutinib dose reduction in patients diagnosed with chronic lymphocytic leukaemia: are we doing it right?

Authors :
J Boo Rodríguez
A Ros Olaso
I Beristain Aramendi
A Eceiza Díez
A Latasa Berasategui
C Saiz Martínez
MJ Garcia de Andoin Barandiaran
J Landa Alberdi
D García Echeverría
G Lizeaga Cundin
Source :
Section 4: Clinical pharmacy services.
Publication Year :
2023
Publisher :
British Medical Journal Publishing Group, 2023.

Details

Database :
OpenAIRE
Journal :
Section 4: Clinical pharmacy services
Accession number :
edsair.doi...........71075693921b1cc5191cc37d9b4cc993